Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Louise Rodino-Klapac Insider Profile
4 Followers
Louise Rodino-Klapac, Head of R&D, CSO at Sarepta Therapeutics, holds 68.07K shares in Sarepta Therapeutics (Ticker: SRPT).
Louise Rodino-Klapac has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Louise Rodino-Klapac's holdings
Insider Roles
Head of R&D, CSO
Roles that Louise Rodino-Klapac holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 29, 2021 - Nov 29, 2022
Return:+46.60%
The most profitable trade made by Louise Rodino-Klapac
Louise Rodino-Klapac's Trading History
List of latest transactions for each holding click on a transaction to see Louise Rodino-Klapac's performance on stock
You May Also Like
Louise Rodino-Klapac insider profile FAQ
What is the percentage of profitable transactions made by Louise Rodino-Klapac?
The percentage of profitable transactions made by Louise Rodino-Klapac is ―.
What is the average return per transaction made by Louise Rodino-Klapac?
The average return per transaction made by Louise Rodino-Klapac is ―.
What stocks does Louise Rodino-Klapac hold?
Louise Rodino-Klapac holds: SRPT stocks.
What was Louise Rodino-Klapac’s latest transaction?
Louise Rodino-Klapac latest transaction was an Uninformative Sell of $173.63K.
What was Louise Rodino-Klapac's most profitable transaction?
Louise Rodino-Klapac’s most profitable transaction was an Informative Buy of SRPT stock on November 29, 2021. The return on the trade was 46.60%.
What is Louise Rodino-Klapac's role in Sarepta Therapeutics?
Louise Rodino-Klapac's role in Sarepta Therapeutics is Head of R&D, CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.